Clinical Trials Logo
  1. Home
  2. Keratosis
  3. NCT00115154

Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands

Keratosis Clinical Trial

Official title:
Vehicle-Controlled, Double-Blind Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Upper Extremities

Clinical Trial Summary

The purpose of this study is to evaluate the safety and efficacy of imiquimod 5% cream compared to vehicle cream in the treatment of Actinic Keratosis (AK) on the arm and/or hand when the cream is applied once daily 2 days per week for 16 weeks.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00115154
Study type Interventional
Source Graceway Pharmaceuticals, LLC
Contact
Status Completed
Phase Phase 4
Start date May 2005
Completion date September 2006
View Details
See also
  Status Clinical Trial Phase
Completed NCT00239135 - Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel Phase 2
Recruiting NCT06206681 - Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid Tumors
Recruiting NCT04336514 - A Longitudinal Quantitative Assessment of the Effectiveness of Metatarsal Pads on Plantar Pressures N/A
Completed NCT00116649 - Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis Phase 4
Recruiting NCT05942794 - Identification of Oral Lesions Through an Autofluorescence System N/A
Withdrawn NCT02851693 - Study of Imaging Characteristics OCT of Skin Lesions Requiring Biopsy / Resection N/A
Withdrawn NCT02813902 - A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors Phase 1
Completed NCT00121511 - The Effect of Efudex Treatment on Photoaged Skin N/A
Completed NCT00114023 - 1-Year Follow up to the 1473-IMIQ Study Phase 3
Completed NCT05060237 - Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp Phase 1
Recruiting NCT02737176 - Tobacco Cessation Intervention Study for Oral Diseases N/A
Completed NCT00110682 - Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses Phase 4